Sarissa Capital Acquisition Corp. (SRSA)
| Market Cap | 250.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 12.65M |
| Shares Out | 25.00M |
| EPS (ttm) | 0.46 |
| PE Ratio | 21.98 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,304 |
| Open | 10.00 |
| Previous Close | 10.00 |
| Day's Range | 10.00 - 10.00 |
| 52-Week Range | 9.72 - 10.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SRSA
Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut. [Read more...]
Financial Performance
Financial StatementsNews
Sarissa Capital Acquisition Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report
GREENWICH, Conn., May 28, 2021 /PRNewswire/ -- Sarissa Capital Acquisition Corp. (NASDAQ: SRSA) (the "Company"), today announced it received a notice on May 28, 2021 from the Listing Qualifications Depa...
Sarissa Capital Acquisition Corp. Announces Pricing of $175,000,000 Initial Public Offering
GREENWICH, Conn., Oct. 20, 2020 /PRNewswire/ -- Sarissa Capital Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 17,500,000 units, at a price of $10.00 per...